Table 2.
Parameter | Univariable analysis |
Multivariable analysis |
||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
Age | 1.012 | 0.983–1.041 | .435 | 0.992 | 0.959–1.027 | .668 |
FIGO | 1.993 | 1.361–2.918 | < .001 | 1.304 | 0.774–2.292 | .332 |
Grade | 2.201 | 1.469–3.297 | < .001 | 1.332 | 0.776–2.251 | .304 |
Lymphovascular invasion | 1.084 | 1.052–1.118 | < .001 | 1.010 | 0.942–1.049 | .624 |
Myometrial invasion | 1.032 | 1.011–1.048 | < .001 | 1.028 | 0.911–1.037 | .698 |
MELF pattern | 4.115 | 2.240–7.558 | < .001 | 1.748 | 0.870–3.513 | .117 |
No. of vessels | 1.036 | 1.026–1.045 | < .001 | 1.000 | 0.999–1.000 | .623 |
Area of vessels | 1.001 | 1.001–1,001 | < .001 | 1.018 | 1.002–1.033 | .025 |
VEGF | 1.078 | 1.058–1.098 | < .001 | 1.049 | 1.022–1.077 | < .001 |
Galectin-1 | 1.071 | 1.054–1089 | < .001 | 1.049 | 1.025–1.074 | < .001 |
CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; MELF, microcystic, elongated and fragmented; VEGF, vascular endothelial growth factor.